As metformin improves resistance to insulin sensitivity and glucose metabolism, we wondered if metformin combined with DGEC would have a synergistic effect in the amelioration of NAFLD and T2DM. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.